TY - JOUR
T1 - Methadone induced physical dependence in the rat
AU - Ling, Geoffrey S.F.
AU - Tappe, Nancy S.
AU - Inturrisi, Charles E.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1984/2/13
Y1 - 1984/2/13
N2 - Although the morphine withdrawal syndrome has been well described in the rat, a syndrome having similar characteristics has not been demonstrated following chronic methadone treatment. In this study we describe the behavioral effects produced by naloxone (4 mg/kg sc) following 72 hours of continuous iv infusion of methadone, (12.2 ug/kg/min), morphine (12.2 to 97.9 ug/kg/min) or saline. The cessation of methadone or morphine but not saline treatment followed by naloxone resulted in graded signs including wet dog shakes, escape attempts, self-stimulation and body weight loss and quantal signs including diarrhea, ear blanching, exophthalmos, ptosis, tachypnea and teeth chattering. These results indicate that this mode of methadone administration produces physical dependence characterized by a morphine-like withdrawal syndrome in the rat.
AB - Although the morphine withdrawal syndrome has been well described in the rat, a syndrome having similar characteristics has not been demonstrated following chronic methadone treatment. In this study we describe the behavioral effects produced by naloxone (4 mg/kg sc) following 72 hours of continuous iv infusion of methadone, (12.2 ug/kg/min), morphine (12.2 to 97.9 ug/kg/min) or saline. The cessation of methadone or morphine but not saline treatment followed by naloxone resulted in graded signs including wet dog shakes, escape attempts, self-stimulation and body weight loss and quantal signs including diarrhea, ear blanching, exophthalmos, ptosis, tachypnea and teeth chattering. These results indicate that this mode of methadone administration produces physical dependence characterized by a morphine-like withdrawal syndrome in the rat.
UR - http://www.scopus.com/inward/record.url?scp=0021367673&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021367673&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(84)90233-9
DO - 10.1016/0024-3205(84)90233-9
M3 - Article
C2 - 6538254
AN - SCOPUS:0021367673
SN - 0024-3205
VL - 34
SP - 683
EP - 690
JO - Life Sciences
JF - Life Sciences
IS - 7
ER -